Alfasigma has entered into an exclusive licensing agreement with PhaseBio Pharmaceuticals, Inc., for the commercialization of bentracimab in 49 countries across Europe and other key markets.
Venous-lymphatic World International Network foundation (v-WIN), a no profit global organization dedicated to research and education in the venous & lymphatic field has developed a public and health professional awareness not-for-profit project called ...